BDBM426419 (2-(2H-1,2,3-triazol-2-yl)phenyl)((2R,5R)-5-((3-(difluoromethyl)imidazo[1,2-a]pyrazin-8-yl)oxy)-2-methylpiperidin-1-yl)methanone::US10526336, Example 38

SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1-n1nccn1)Oc1nccn2c(cnc12)C(F)F

InChI Key InChIKey=QWMDVLUNTCAPNA-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 426419   

TargetOrexin receptor type 2(Human)
Merck, Sharp & Dohme

US Patent
LigandPNGBDBM426419(US10526336, Example 38 | (2-(2H-1,2,3-triazol-2-yl...)
Affinity DataIC50: 17.6nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2020
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Merck, Sharp & Dohme

US Patent
LigandPNGBDBM426419(US10526336, Example 38 | (2-(2H-1,2,3-triazol-2-yl...)
Affinity DataIC50: 1.79E+3nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/25/2020
Entry Details
US Patent